Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02943473 · OUTCOME

Change in Serum C-terminal Telopeptide (CTX)

Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients · Source last updated 2020-12-16

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
baseline and up to one year

What was measured

Bone Related Biomarker Changes

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
anticipated Posting Date
2021-03
denom Units Selected
Participants
description
Bone Related Biomarker Changes
reporting Status
NOT_POSTED
time Frame
baseline and up to one year
title
Change in Serum C-terminal Telopeptide (CTX)
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice